ABL Bio Technologies informs about quarterly statement on investor complaints

19 Jul 2016 Evaluate

ABL Bio Technologies has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1768.75
Dr. Reddys Lab 1337.30
Cipla 1448.00
Lupin 2155.25
Zydus Lifesciences 1000.80
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.